The ANBERNIC RG DS is now available for pre-order, starting at $93.99. It features two four-inch IPS displays, with a DS-like clamshell form factor. Shipping will begin before December 15, with prices ...

The RG DS will be priced at under $100 and is capable of emulating both Nintendo DS and 3DS titles. The RG DS will be priced at under $100 and is capable of emulating both Nintendo DS and 3DS titles.

Dual-screen handheld game consoles are having a moment. The AYANEO Pocket DS is a premium model that went up for pre-order this summer for $400 and up. The AYN Thor comes in two models: one with ...

What is the DS No 8? Well, it’s not an SUV, a coupe or a perfume. This is the flagship of the DS brand, an offshoot of Citroën, which is a sister company of Peugeot, both of which are now part of the ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Over the years, Nintendo has given us many consoles from mobile devices like the GameBoy to home ...

Gaming handheld maker AMBERNIC is officially teasing a new dual-screen console. The AMBERNIC RG DS is rumored to run Android for Nintendo DS emulation. The console also borrows its design from the ...

The DS No4 hatchback is certainly a distinctive offering in the competitive, premium family hatchback market and one that has plenty of appeal. A smooth ride and refined character help it mount a real ...

Meghan Markle has been lampooned after revealing a 'tacky' tote with her royal initials emblazoned across it. The Duchess of Sussex posted a reel on Instagram charting her PR blitz in New York and ...

The Duchess of Sussex showed off a tote featuring "DS" in oversized letters via an Instagram video Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern monarchies and the world's ...

Abstract: This article proposes a multi-objective optimization method for the optimization design of a new dual-stator arc permanent magnet machine (DS-APMM) which can be applied on the direct-drive ...

First presentation of clinical data from the sixth DXd antibody drug conjugate from the oncology pipeline of Daiichi Sankyo Early results support continued development of DS-3939, a potential first-in ...